UK markets open in 3 hours 23 minutes

UpHealth, Inc. (UPHL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5850-0.0450 (-7.14%)
At close: 03:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.00M
Enterprise value 158.50M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.08
Price/book (mrq)0.20
Enterprise value/revenue 1.22
Enterprise value/EBITDA -0.33

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 3-65.99%
S&P500 52-week change 329.31%
52-week high 32.0400
52-week low 30.1510
50-day moving average 30.8833
200-day moving average 30.7698

Share statistics

Avg vol (3-month) 359.79k
Avg vol (10-day) 346.79k
Shares outstanding 518.81M
Implied shares outstanding 620.26M
Float 89.79M
% held by insiders 146.74%
% held by institutions 110.00%
Shares short (30 Nov 2023) 4628.85k
Short ratio (30 Nov 2023) 41.17
Short % of float (30 Nov 2023) 45.54%
Short % of shares outstanding (30 Nov 2023) 43.54%
Shares short (prior month 31 Oct 2023) 4679.31k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 309 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -44.49%
Operating margin (ttm)-6.37%

Management effectiveness

Return on assets (ttm)1.06%
Return on equity (ttm)-69.98%

Income statement

Revenue (ttm)130M
Revenue per share (ttm)7.34
Quarterly revenue growth (yoy)-57.20%
Gross profit (ttm)N/A
EBITDA 15.81M
Net income avi to common (ttm)-57.84M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.55M
Total cash per share (mrq)0.14
Total debt (mrq)154.27M
Total debt/equity (mrq)279.96%
Current ratio (mrq)0.75
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-17.67M
Levered free cash flow (ttm)-22.22M